Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 27)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for CYTK: the economy's impact on CYTK's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 PriceTarget Research, Inc. N/A Cytokinetics has a current Overall Rating of D (Negative). 7 $25 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CYTOKINETICS -- CYTK 1 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CYTOKINETICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALTUQ , CYTK , IMMU , VITA , TRBN , VICL -- DRUGS 3 $4 View Abstract
31-Jan-10 Zacks Investment Research Inc. N/A CYTOKINETCS INC (CYTK) Zacks Company Snapshot 1 $10 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
25-Jan-10 Argus Research Corporation David Coleman Vickers Weekly Insider, 01/25/10 29 $50 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
Next 17

Independent Reports (Showing 1 to 10 of 27)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for CYTK: the economy's impact on CYTK's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
8-Feb-10 PriceTarget Research, Inc. N/A Cytokinetics has a current Overall Rating of D (Negative). 7 $25 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: CYTOKINETICS -- CYTK 1 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CYTOKINETICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALTUQ , CYTK , IMMU , VITA , TRBN , VICL -- DRUGS 3 $4 View Abstract
31-Jan-10 Zacks Investment Research Inc. N/A CYTOKINETCS INC (CYTK) Zacks Company Snapshot 1 $10 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
25-Jan-10 Argus Research Corporation David Coleman Vickers Weekly Insider, 01/25/10 29 $50 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CYTOKINETICS INC 5 $25 View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.